# Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System

> **NCT04764370** · NA · COMPLETED · sponsor: **Hangzhou Endonom Medtech Co., Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Aortic Arch; Aneurysm, Dissecting

## Interventions

- **DEVICE:** WeFlow-Ach Moduler Embedded Branch Stent Graft System

## Key facts

- **NCT ID:** NCT04764370
- **Lead sponsor:** Hangzhou Endonom Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-28
- **Primary completion:** 2022-10-22
- **Final completion:** 2022-10-22
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04764370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04764370, "Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04764370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*